Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Accounts Payables (2020 - 2023)

Historic Accounts Payables for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $2.4 million.

  • Cullinan Therapeutics' Accounts Payables changed 0.0% to $2.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $2.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.7 million for FY2022, which is 1606.18% down from last year.
  • As of Q3 2023, Cullinan Therapeutics' Accounts Payables stood at $2.4 million, which was down 0.0% from $2.5 million recorded in Q2 2023.
  • Over the past 5 years, Cullinan Therapeutics' Accounts Payables peaked at $9.7 million during Q4 2020, and registered a low of $1.5 million during Q2 2021.
  • In the last 4 years, Cullinan Therapeutics' Accounts Payables had a median value of $2.6 million in 2022 and averaged $3.5 million.
  • As far as peak fluctuations go, Cullinan Therapeutics' Accounts Payables surged by 10523.18% in 2022, and later crashed by 6779.26% in 2023.
  • Quarter analysis of 4 years shows Cullinan Therapeutics' Accounts Payables stood at $9.7 million in 2020, then tumbled by 67.26% to $3.2 million in 2021, then dropped by 16.06% to $2.7 million in 2022, then fell by 9.62% to $2.4 million in 2023.
  • Its last three reported values are $2.4 million in Q3 2023, $2.5 million for Q2 2023, and $2.0 million during Q1 2023.